Skip to main content
Fig. 3 | Diabetology & Metabolic Syndrome

Fig. 3

From: Effects of finerenone and glucagon-like peptide 1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus: a systematic review and meta-analysis

Fig. 3

Meta-analysis of finerenone and GLP1-RA trials on MACE. (A) Meta-analysis of finerenone and GLP1-RA trials on MACE stratified by drug class. (B) Meta-analysis of finerenone and GLP1-RA trials on MACE stratified by established atherosclerotic cardiovascular disease (ASCVD). Forest plot showing the treatment estimates of each drug class in each subgroup using random effects

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us